Research Article

Fluvastatin-Pretreated Donor Cells Attenuated Murine aGVHD by Balancing Effector T Cell Distribution and Function under the Regulation of KLF2

Figure 3

Fluvastatin pretreatment adjust migration ability of donor derived cells. (a) Total mononuclear cell number. (b) Flow cytometric analysis of CD3+ T cell proportion and (c) absolute number of CD3+ T cells in thymus, spleen, lymph nodes, and blood from recipients receiving Fluvastatin-pretreated or Fluvastatin-unpretreated donor cells. (d) Infiltration of CD3+ T cells in GVHD target organs were measured (cell number/section) by immunohistochemical staining on days 3, 7, 14, 21, and 28 (e) posttransplantation. Slices of target organs were shown (×200). Data represents the from 3 independent experiments ( per time point). , , n.s .